Mixed Endometrial Epithelial Carcinoma: Epidemiology, Treatment and Survival Rates—A 10-Year Retrospective Cohort Study from a Single Institution
Journal of Clinical Medicine · 05.10.2023 · 12 (19) · 6373
DOI: 10.3390/jcm12196373 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.10.2023. Verfasst von Christina Pappa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecological Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mixed endometrial carcinoma (MEEC) refers to rare endometrial tumours that are composed of two or more distinct histotypes, at least one of which is serous or clear cell. The aim of this study was to evaluate the epidemiology, treatment outcomes and survival rates of patients with mixed endometrial carcinoma. The medical records of 34 patients diagnosed with MEEC between March 2010 and January 2020 were reviewed retrospectively. Clinicopathological variables and treatment strategies were assessed, and overall survival and disease-free survival rates were evaluated. The histology of endometrioid and serous component was found in 26 (76.5%) patients, followed by serous and clear-cell components (5/34, 14.5%) and mixed endometrioid serous and clear-cell components (3/34, 8.8%). The median age at diagnosis was 70 years (range 52–84), and the median follow-up time was 55 months. The 5-year disease-free survival and the 5-year overall survival were 50.4% and 52.4%, respectively. Advanced disease stage was identified as an independent predictor of inferior disease-free (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynaecological Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, UK.
- Gynaecology-Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
- Unit of Obstetrics and Gynecology, "Paolo Giaccone" Hospital, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy.
- Department of Clinical and Experimental Sciences, University of Brescia, 25136 Brescia, Italy.
- Department of Gynaecological Oncology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby DE22 3NE, UK.
ORCID-Profile: Sarah Louise Smyth, Andreas Zouridis, Alisha Sattar, Mostafa Abdalla, Antonio Simone Laganà, Hooman Soleymani Majd
Zitieren
APA
Pappa, C., Le Thanh, V., Smyth, S. L., Zouridis, A., Kashif, A., Sadeghi, N., Sattar, A., Damato, S., Abdalla, M., Laganà, A. S., Ferrari, F., Kehoe, S., Addley, S., & Soleymani Majd, H. (2023). Mixed Endometrial Epithelial Carcinoma: Epidemiology, Treatment and Survival Rates—A 10-Year Retrospective Cohort Study from a Single Institution. Journal of Clinical Medicine, 12(19), 6373. https://doi.org/10.3390/jcm12196373
Vancouver
Pappa C, Le Thanh V, Smyth SL, Zouridis A, Kashif A, Sadeghi N, et al. Mixed Endometrial Epithelial Carcinoma: Epidemiology, Treatment and Survival Rates—A 10-Year Retrospective Cohort Study from a Single Institution. Journal of Clinical Medicine. 2023;12(19):6373. doi:10.3390/jcm12196373
BibTeX
@article{Pappa2023,
author = {Pappa, Christina and Le Thanh, Valentina and Smyth, Sarah Louise and Zouridis, Andreas and Kashif, Ammara and Sadeghi, Negin and Sattar, Alisha and Damato, Stephen and Abdalla, Mostafa and Laganà, Antonio Simone and Ferrari, Federico and Kehoe, Sean and Addley, Susan and Soleymani Majd, Hooman},
title = {Mixed Endometrial Epithelial Carcinoma: Epidemiology, Treatment and Survival Rates—A 10-Year Retrospective Cohort Study from a Single Institution},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {19},
pages = {6373},
doi = {10.3390/jcm12196373}
}
EUVIMED